167 related articles for article (PubMed ID: 18528779)
1. Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism.
Taskapan H; Vieth R; Oreopoulos DG
Int Urol Nephrol; 2008; 40(3):801-5. PubMed ID: 18528779
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Life-threatening complications of vitamin D intoxication due to over-the-counter supplements.
Kaptein S; Risselada AJ; Boerma EC; Egbers PH; Nieboer P
Clin Toxicol (Phila); 2010 Jun; 48(5):460-2. PubMed ID: 20515399
[TBL] [Abstract][Full Text] [Related]
4. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
[TBL] [Abstract][Full Text] [Related]
5. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A and Hydrochlorothiazide Causing Severe Hypercalcemia in a Patient With Primary Hyperparathyroidism.
Varghese RT; Khasawneh K; Desikan RK; Subramaniam A; Weaver T; Nair GKV
J Investig Med High Impact Case Rep; 2019; 7():2324709618823805. PubMed ID: 30791717
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hypercalcemia in relation to hyperparathyroidism.
Pellitteri PK
Otolaryngol Clin North Am; 2010 Apr; 43(2):389-97, x. PubMed ID: 20510722
[TBL] [Abstract][Full Text] [Related]
8. The other side of vitamin D therapy:
a case series of acute kidney injury due to malpractice-related vitamin D intoxication
.
Wani M; Wani I; Banday K; Ashraf M
Clin Nephrol; 2016 Nov; 86 (2016)(11):236-241. PubMed ID: 27719737
[TBL] [Abstract][Full Text] [Related]
9. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
[TBL] [Abstract][Full Text] [Related]
10. Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report.
Hussain M; Hammam M
J Med Case Rep; 2016 Jun; 10():166. PubMed ID: 27277007
[TBL] [Abstract][Full Text] [Related]
11. [Severe hypercalcemia of unusual cause, looking for the culprit: Case report and review of the literature].
Jalbert M; Mignot A; Gauchez AS; Dobrokhotov AC; Fourcade J
Nephrol Ther; 2018 Jun; 14(4):231-236. PubMed ID: 29709532
[TBL] [Abstract][Full Text] [Related]
12. Coexisting primary hyperparathyroidism and sarcoidosis in a patient with severe hypercalcemia.
Yoshida T; Iwasaki Y; Kagawa T; Sasaoka A; Horino T; Morita T; Hashimoto K
Endocr J; 2008 May; 55(2):391-5. PubMed ID: 18385529
[TBL] [Abstract][Full Text] [Related]
13. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
[TBL] [Abstract][Full Text] [Related]
14. Gestational hypercalcemia: Prevalence and biochemical profile.
Schoenmakers I; Piec I; Baban S; Bärebring L; Green D; Washbourne CJ; Tang JCY; Fraser WD; Augustin H
J Steroid Biochem Mol Biol; 2020 May; 199():105611. PubMed ID: 32007562
[TBL] [Abstract][Full Text] [Related]
15. Different vitamin D substrate-product relationship after oral vitamin D supplementation in familial benign hypercalcemia, primary hyperparathyroidism, and healthy controls.
Bevilacqua M; Invernizzi M; Righini V; Carda S; Cisari C
Eur J Endocrinol; 2011 May; 164(5):833-8. PubMed ID: 21310873
[TBL] [Abstract][Full Text] [Related]
16. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
Majid H; Khan AH; Riaz M; Karimi H; Talati J
Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
18. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial.
Gallagher JC; Sai A; Templin T; Smith L
Ann Intern Med; 2012 Mar; 156(6):425-37. PubMed ID: 22431675
[TBL] [Abstract][Full Text] [Related]
19. [Endocrine diseases presenting with hypo- or hypercalcemia].
Inaba M; Nishizawa Y
Nihon Rinsho; 2006 Sep; Suppl 3():536-41. PubMed ID: 17022605
[No Abstract] [Full Text] [Related]
20. Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hydroxyvitamin d status.
Bussey AD; Bruder JM
Endocr Pract; 2005; 11(1):37-42. PubMed ID: 16033734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
